Clinical Significance of M1/M2 Macrophages and Related Cytokines in Patients with Spinal Tuberculosis

Table 2

Clinical data of spinal TB group and control group.

	Experimental	Control
Age
Gender
Male	17 (47%)	12 (48%)
Female	19 (53%)	13 (52%)
Ethnicity
Han	8 (22%)	7 (28%)
Minority	28 (78%)	18 (72%)
Occupation
Labor-type	10 (28%)	6 (24%)
Nonlabor type	17 (47%)	12 (48%)
Freelance	9 (25%)	7 (28%)
Risk factor
History of TB	4 (11%)	0
HIV	0	0
Main symptoms
Numbness of both lower limbs	10 (28%)	0
Neuropathic pain	35 (97%)	0
Systemic symptoms	11 (31%)	0
X-ray
Column destruction	16 (44%)	0
Paravertebral tissue shadow	14 (39%)	0
Bone chelation and hardening	1 (2%)	0
Osteosis	1 (2%)	0
Biochemical analysis
Increased T-SPORT	16 (44.4%)	0
Increased CRP	22 (61%)	0
Increased leukocyte	2 (6%)	1 (4%)
Increased M	25 (69.4%)	1 (4%)

Note: TB: tuberculosis; HIV: Human Immunodeficiency Virus; CRP: C-reaction protein; T-SPOT.TB: T cell spot test tuberculosis; M (Monocytes).